Merck KGaA (OTCMKTS:MKGAF – Get Free Report) is projected to issue its results before the market opens on Thursday, August 6th. Analysts expect Merck KGaA to post earnings of $2.31 per share and revenue of $6.0418 billion for the quarter.
Merck KGaA Trading Down 0.8%
Merck KGaA stock opened at $166.25 on Thursday. Merck KGaA has a 52 week low of $116.68 and a 52 week high of $175.56. The company has a debt-to-equity ratio of 0.27, a quick ratio of 0.84 and a current ratio of 1.31. The firm has a market capitalization of $21.49 billion, a PE ratio of 25.38 and a beta of 0.96. The business’s 50-day simple moving average is $159.35 and its 200-day simple moving average is $146.96.
About Merck KGaA
Merck KGaA, headquartered in Darmstadt, Germany, is a long-established multinational chemical and pharmaceutical company with roots dating back to 1668. Operating under the brand Merck Group (and using distinct consumer-facing names in certain regions to avoid confusion with other companies of similar name), the company is privately controlled by the Merck family and organizes its activities across multiple business units that serve customers in Europe, the Americas, Asia-Pacific and beyond.
The company’s operations are organized mainly into three businesses.
Featured Stories
- Five stocks we like better than Merck KGaA
- Why SK hynix Could Be the Best AI Chip Stock to Buy Now
- Seagate Technology Stock Surges as Earnings Beat Silences AI Doubters
- Alphabet Is Down 18% From Its High After a Stellar Quarter—Overdone, or More Downside Ahead?
- Why Bloom Energy May Be the Most Important AI Infrastructure Stock
Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.
